Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 23.51M P/E - EPS this Y 25.10% Ern Qtrly Grth -
Income -29.74M Forward P/E -1.15 EPS next Y 223.70% 50D Avg Chg -7.00%
Sales 4.49M PEG - EPS past 5Y - 200D Avg Chg -34.00%
Dividend N/A Price/Book 2.37 EPS next 5Y - 52W High Chg -79.00%
Recommedations 2.00 Quick Ratio 0.99 Shares Outstanding 19.37M 52W Low Chg 12.00%
Insider Own 5.63% ROA -131.96% Shares Float 17.24M Beta 1.02
Inst Own 18.02% ROE - Shares Shorted/Prior 1.32M/1.42M Price 2.04
Gross Margin - Profit Margin - Avg. Volume 54,282 Target Price 11.50
Oper. Margin -2,378.75% Earnings Date Nov 12 Volume 45,282 Change -4.67%
About Palatin Technologies, Inc.

Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing oral PL8177, a selective MC1r agonist peptide that is in Phase 2 clinical trial for the treatment of inflammatory bowel diseases. In addition, the company engages in the development of PL9643, a peptide melanocortin agonist active at multiple MCrs, including MC1r and MC5r for anti-inflammatory ocular indications, such as dry eye disease, which is in Phase 3 clinical trial; and melanocortin peptides for diabetic retinopathy. Further, it is developing PL8177, an oral peptide formulation for treatment of ulcerative colitis, which entered Phase 2 clinical trials. The company was founded in 1986 and is based in Cranbury, New Jersey.

Palatin Technologies, Inc. News
11/15/24 Q1 2025 Palatin Technologies Inc Earnings Call
11/15/24 Palatin Technologies Inc (PTN) Q1 2025 Earnings Call Highlights: Strategic Shifts Amid Revenue ...
11/14/24 Palatin Reports First Quarter Fiscal Year 2025 Operating/Financial Results
11/08/24 Palatin to Report First Quarter Fiscal Year 2025 Results; Teleconference and Webcast to be held on November 14, 2024
11/04/24 Palatin Presents Data on Novel Melanocortin 4 Receptor Selective Oral Small Molecule PL7737 Obesity Program at ObesityWeek® 2024
10/31/24 Palatin Completes Enrollment in Phase 2 Clinical Study of Bremelanotide (MC4R Agonist) Co-Administered with Tirzepatide (GLP-1/GIP) for the Treatment of Obesity
10/24/24 Inflammatory Disease Healing Data via Palatin's Novel Melanocortin Receptor Agonists Presented at the 19th Annual Peptide Therapeutics Symposium
10/23/24 Palatin Presents Foundational Data on Novel and Highly Selective Melanocortin 4 Receptor Agonists at the 19th Annual Peptide Therapeutics Symposium
10/07/24 Palatin Receives Notice of Non-Compliance from NYSE American
10/02/24 Q4 2024 Palatin Technologies Inc Earnings Call
10/02/24 Palatin Technologies Inc (PTN) Q4 2024 Earnings Call Transcript Highlights: Strategic Moves and ...
10/01/24 Palatin Reports Fourth Quarter and Fiscal Year Ended 2024 Financial Results, Provides Update on Clinical Programs, Strategic Priorities, and Anticipated Milestones
09/26/24 Palatin to Report Fourth Quarter and Fiscal Year End 2024 Results
09/09/24 Palatin Provides Update on Clinical Programs, Strategic Priorities, and Anticipated Milestones
08/28/24 FDA Confirms Acceptability of Palatin's Remaining Phase 3 Pivotal Clinical Trials for PL9643 in Dry Eye Disease (DED)
08/23/24 Palatin Technologies doses first subject in Phase II obesity treatment trial
08/22/24 First Patient Dosed in Phase 2 Clinical Study of Palatin's Bremelanotide Co-Administered with Tirzepatide (GLP-1) for the Treatment of Obesity
07:00 AM Palatin Announces Exercise of Warrants for Approximately $6.1 Million Gross Proceeds
03:32 AM Palatin initiates Bremelanotide-PDE5i Phase II trial for ED
06/20/24 Palatin Announces the Initiation of a Phase 2 Clinical Study of Bremelanotide Co-Administered with a PDE5i for the Treatment of Erectile Dysfunction (ED)
PTN Chatroom

User Image Rolo2024 Posted - 19 hours ago

$PTN Someone would have to be an idiot to sell at this point! Potentially big news coming this quarter that could lead to a partnership with large company. Currently holding 2450 shares with a $5K loss so I will ride this into the sunset.

User Image Tpharma Posted - 1 day ago

$PTN The usual mob of traders looks like they are trying their hardest to lower the price, but less people are panic selling now as we head towards the BREAKOUT results being released. If the traders can hammer the price down to below 80c then I will buy another 10k shares before the results are released next month. If it goes below 80c then we will get the usual 50% rebound anyway, easy profit.

User Image braves1983 Posted - 1 day ago

$PTN 90 cents now. PTN never dissappoints. it also never does anything

User Image Tpharma Posted - 1 day ago

$PTN Looks like we just have a pile of utter garbage on our books. They’ve been doing the diabetic nephropathy trial for two years now and haven’t even released the results yet. What kind of crap biotech does that? Let’s be real, wait for the usual characters scaremongering to come in here and scare about cash (they do it every 4 weeks), then when the price dips buy in, sell after two weeks when it has peaked again. Just rinse and repeat, rinse and repeat. That’s about all this stock is good for. It might go down a bit lower first and then will rebound back to $1.3 again. Buy at 80c and sell at $1.25. Rinse and repeat, the company aint gonna do shit, they keep promising results, they deliver nothing. Rinse and repeat.

User Image BriamG316 Posted - 2 days ago

🔥 $PTN looks like it's gearing up for a breakout year! Palatin’s Vyleesi is already the only FDA-approved treatment for female sexual dysfunction, and with new partnerships and increasing market share, they could dominate the space. Plus, their pipeline is growing with other exciting treatments in the works. 💉 $PTN is undervalued at these levels. Don't miss the chance to get in before the next wave of investor interest. 📈 #BiotechInvesting #PharmaStocks #Innovation #PTN

User Image braves1983 Posted - 2 days ago

$PTN when are we getting results here??

User Image Darkwatcher1 Posted - 2 days ago

$AITX $DG $DJT $PTN $SQM 🤘🤘🤘🤘

User Image BriamG316 Posted - 3 days ago

💥 $PTN could be your next 10x biotech play! Palatin's Vyleesi is gaining traction, and with a growing market for treatments related to sexual health, $PTN is in the right place at the right time. The company just secured another milestone payment, pushing them closer to profitability. 💰 With a small market cap and a big upside potential, don't sleep on this one. 2024 could be the year $PTN breaks out! $UAVS $VINO #BiotechStocks #SmallCap #Pharma #PTN

User Image RunningRobert1 Posted - 3 days ago

$PTN Palatin Technologies Inc PTN 3Q 2024 Summary 18Nov2024 https://youtu.be/rvTZCrrEsd0 So I want to be excited for this company, but they need cash to get out of 2024, I am hoping they can make some kind of deal to help ease the cash issues and the net loss,

User Image Darkwatcher1 Posted - 5 days ago

$PTN who misses the hoax! 🤣🤷🏻‍♂️ it’s been 4 yrs and he’s been gone… what’s up? I know you are still out there… how have you been?…. 😂🤷🏻‍♂️

User Image Tpharma Posted - 6 days ago

$PTN Look at the whole industry. All biotech companies crashed today due to the RFK jnr announcement. This company always gets hit harder because batches of 100 shares are always sold in rapid succession to lower the share price and help other accumulate at lower prices. But none of it matters, all that matters are the P2 BREAKOUT results now.

User Image braves1983 Posted - 6 days ago

$PTN why the fuck is this down 15 cents?? stop the bullshit already

User Image braves1983 Posted - 6 days ago

$PTN garbage garbage garbage

User Image Tpharma Posted - 6 days ago

$PTN There’s no reason for this to fall right now other than intraday trading and the usual monthly up/down movement that day traders cause. Everything is still to play for with the release of the BREAKOUT Diabetic nephropathy trial results in the next six weeks, before end of year. Don’t be a fool and sell your shares now before the chance to multibag, it’s just day traders trying to lower the price to scare.

User Image Tpharma Posted - 6 days ago

$PTN I keep telling you, yet it’s not going into your brain for some reason. We have enough cash to last for our Diabetic neohropathy BREAKOUT trial results to come out. You listened to the call, then you know that they said again BREAKOUT results are still on for this quarter. What other catalysts are you hoping for? Trial results are what make biotech companies move. Why did you even invest in Palatin if not for trials?

User Image Rollinhumbl23 Posted - 6 days ago

$PTN ALL i want for Christmas this year for Aitx to hit a dollar

User Image Badolo83 Posted - 6 days ago

$PTN after listening in and re-reading the script, speak about realizing value and return value to shareholders. Rather than invest and grow themselves. de facto cash is 5m as of 30/09. that should get them to next catalyst. Will observe and perhaps buy some more as long as is down here still.

User Image Darkwatcher1 Posted - 6 days ago

$PTN $AITX and Steve said…

User Image Tpharma Posted - 6 days ago

$PTN Are the BREAKOUT P2 trial results in Diabetic nephropathy going cause our share price to finally breakout too? The trial has take two years and results are coming this quarter. Good luck to all holders

User Image braves1983 Posted - 1 week ago

$PTN only goes up out of the blue

User Image Stocks787 Posted - 1 week ago

$PTN

User Image braves1983 Posted - 1 week ago

$PTN im amazed how this fell 13% before the actual call and also knowing they ”beat” expectations…. its like it was going down no matter what

User Image Tpharma Posted - 1 week ago

$PTN Incorrect. Diabetic nephropathy results are this quarter. Obesity results are next quarter. You need to calm down dude, just wait for the results or sell your shares.

User Image stockraja Posted - 1 week ago

$PTN multiple deals lol

User Image braves1983 Posted - 1 week ago

$PTN results pushed back yet another quarter. see you in 2025

User Image braves1983 Posted - 1 week ago

$PTN so it’s stuck at 1.04?? why? i mean it already fell 15%….. are they waiting for the actual call to be over with to fall further?? like the conference really means anything.

User Image Tpharma Posted - 1 week ago

$PTN Why did you invest in a biotech? You do know that the clinical trial results are all that matter, right? If it goes to 75c then I’m buying more. I bought in because of the diabetic nephropathy trial, I’m pleased it’s on track. Why are you so upset?

User Image Stocks787 Posted - 1 week ago

$PTN red market

User Image mikedeatworld Posted - 1 week ago

@Tpharma 2.5M while running trials is basically zero - they have rent to pay, insurance cost, they have to pay Steve and Carl, etc. $PTN

User Image braves1983 Posted - 1 week ago

$PTN 75 cents next week. bullshit trial results. 4 years if bullshit price targets. everything about PTN is bullshit

Analyst Ratings
HC Wainwright & Co. Buy Jun 20, 24
HC Wainwright & Co. Buy Jun 12, 24
HC Wainwright & Co. Buy May 15, 24
HC Wainwright & Co. Buy May 8, 24
HC Wainwright & Co. Buy May 2, 24
HC Wainwright & Co. Buy Feb 28, 24
HC Wainwright & Co. Buy Feb 15, 24
HC Wainwright & Co. Buy Aug 10, 23
HC Wainwright & Co. Buy Aug 8, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
WILLS STEPHEN T Executive VP and CFO.. Executive VP and CFO/COO Dec 06 Sell 2.53 4,998 12,645 327,522 12/08/23
DUNTON ALAN W Director Director Dec 04 Sell 2.47 200 494 45,074 12/06/23
SPANA CARL President and CEO President and CEO Dec 27 Buy 2.23 10,000 22,300 293,604 12/28/22
WILLS STEPHEN T Executive VP and CFO.. Executive VP and CFO/COO Dec 27 Buy 2.22 10,000 22,200 267,101 12/28/22
DUNTON ALAN W Director Director Dec 21 Sell 2.97 200 594 41,420 12/23/22